MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer

EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells

(2013) Giulia M. Stella et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Epidermal Growth Factor Receptor Inhibition in Lung Cancer: Status 2012

(2013) Fred R. Hirsch et al.   Journal of Thoracic Oncology

EGFR inhibitors for wild-type EGFR NSCLC: to use or not to use?

(2013) Jacek Jassem et al.   LANCET ONCOLOGY

Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC

(2013) A.G. Pallis et al.   LUNG CANCER

Surgery for NSCLC in the era of personalized medicine

(2013) Tetsuya Mitsudomi et al.   Nature Reviews Clinical Oncology

Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC)

(2013) Kunihiko Kobayashi et al.   Targeted Oncology

Ataxia–telangiectasia group D complementing gene (ATDC) upregulates matrix metalloproteinase 9 (MMP-9) to promote lung cancer cell invasion by activating ERK and JNK pathways

(2013) Zhong-Ping Tang et al.   TUMOR BIOLOGY

CARMA3 is overexpressed in human glioma and promotes cell invasion through MMP9 regulation in A172 cell line

(2013) Xingjun Feng et al.   TUMOR BIOLOGY

The Role of Epidermal Growth Factor Receptor in Cancer Metastasis and Microenvironment

(2013) Takamitsu Sasaki et al.   Biomed Research International

EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line

(2009) Sangmin Kim et al.   CELLULAR SIGNALLING

The epidermal growth factor receptor ligands at a glance

(2008) Marlon R. Schneider et al.   JOURNAL OF CELLULAR PHYSIOLOGY